한국어
English
日本語
中文(简体)
Lidap Soft Capsule 25mg (Midostaurin)
25mg
Prescription medication
Korea Novartis Co., Ltd.
Midostaurin is an anticancer agent used in the treatment of certain malignant tumors.
MFDS ingredient code M268732
Midostaurin is classified as an antineoplastic drug, primarily used in the treatment of specific cancers such as acute myeloid leukemia. This substance works by inhibiting several protein kinases.
Midostaurin blocks the activity of protein kinases involved in signaling within cancer cells. By doing so, it disrupts the processes by which cancer cells proliferate and survive, thereby inhibiting tumor growth. It is particularly effective against leukemia cells with FLT3 mutations.
Approved uses differ by product. Check each product's information for its actual use.
Midostaurin is a multi-kinase inhibitor that simultaneously inhibits multiple target proteins. This distinguishes it from other anticancer agents that target a single target only. Additionally, it shows selective efficacy in patients with specific gene mutations.
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
Product approval information is based on drug information provided by the Ministry of Food and Drug Safety.
Ingredient and class descriptions are not part of MFDS data and were written separately by Cashdoc.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.